ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EU regulators to review Sandoz’ Neulasta biosimilar
pharmatimes
October 31, 2017The European Medicines Agency has accepted for review Novartis unit Sandoz’ biosimilar of Amgen’s Neulasta. -
Mylan and Biocon Neulasta biosimilar knocked back by FDA
pharmafile
October 12, 2017Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the nod from the FDA, after receiving a CRL related manufacturing plant issues -
Risky endeavours for biosimilars market
europeanpharmaceuticalreview
August 10, 2017Bringing a biosimilar from early development to market is a risky endeavour say Magnus Franzen (left) and Chris Isler, biosimilar experts at PA Consulting Group…
Pharma Sources Insight July 2025
